ST
Sangamo Therapeutics Inc
🇺🇸XNAS.SGMOUnited StatesHealthcare
$0.18USDup +0.05 (+38.46%)ClosedEnd of day11:02 PM
Price$0.18+0.05 (+38.46%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US8006771062
- CUSIP
- 800677106
Company
- Employees
- 142
- Headquarters
- Richmond, United States
- Website
- https://www.sangamo.com
- CEO
- Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Market
- Shares outstanding
- 414.3M
- Market cap
- $74.57M
Highlights
- Market cap
- $74.57M
- EPS LTM
- -$0.32
- P/E LTM
- -0.79
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $34.56M-45.8%down year on year
- Net income
- -$123.33M-55.23%down year on year
- Gross margin
- 89.06%-0.25%down year on year
- Free cash flow
- -$90.46M-101.5%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.